STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
Irina Bancos, MD Adrenas, Corcept, Esteve, Recordati, Xeris (Advisory Board); Adaptyx, Astrazeneca, Camurus, Corcept, Crinetics, Diurnal, Esteve, Neurocrine, Recordati, Sparrow Pharmaceutics, Spruce (Consultant); European Journal of Endocrinology (Editor); Esteve, Recordati (Research Support); Dynamed (Reviewer); Elsevier (Writer).
Shagun Bindlish, MD Golden State Obesity Society (Founder and President), American Diabetes Association journal Clinical Diabetes, Obesity Medicine Association journal Pillars of Medicine (Associate Editor).
John D. Carmichael, MD American Association of Clinical Endocrinologists and Pituitary Society (Member); Novo Nordisk, Camurus, Xeris (Advisory Board); Crinetics, Novo Nordisk (Research Support).
Marcelo Correia, MD, MSc, PhD The Obesity Society (Member); Novartis, Eli Lilly, Novo Nordisk, Stead Family (Iowa), National Institutes of Health, PCORI (Research Support); Novo Nordisk (Advisory Board and Consultant); Genentech/Roche (Advisory Board).
Natalie Cusano, MD, MS Ascendis Pharma, Extend Biosciences (Consultant); Endocrine Practice (Editor); Ascendis Pharma, Takeda/Shire (Research Support); Alexion (Speaker).
Kaniksha Desai, MD Endocrine Practice (Editor); American Thyroid Association, American Association of Clinical Endocrinologists, Thyroid Disease State Network (Member); Medscape Podcast on Thyroid Diseases (Host).
Hans K. Ghayee, DO Corcept (Consultant); SDHB Pheo Para Coalition (Funding); University of Texas Southwestern Medical Center (Royalties).
Sangeeta Kashyap, MD GI Dynamics (Consultant); Fractyl, Inc (Research Support).
E. Michael Lewiecki, MD Ultragenyx, Angitia (Institutional Research Grants); Amgen, Radius, Kyowa Kirin, Angitia, Ascendis (Consultant); Amgen, Radius, Ascendis, Kyowa Kirin (Speaker).
Cecilia C. Low Wang, MD American Association of Clinical Endocrinology, American College of Diabetology, American Heart Association, Clinical Diabetes and Endocrinology Institute (Advisory Board); Clinical Diabetes and Endocrinology Institute, Medical Education Resources, Continuing Education Company (Speaker); Dexcom Inc, Virta Health (Research Funding); American Heart Association (Guidelines Committee); FDA Advisory Committee for Endocrinologic Metabolic Drugs (Committee Member).
Elizabeth McAninch, MD Acella Pharmaceuticals, AbbVie Inc (Consultant); Equilibrate Therapeutics, LLC (Cofounder).
Stephanie Page, MD, PhD Pharmajor International (Consultant).
The following faculty reported no relevant financial relationships: Dima L. Diab, MD; Margaret Flynn Lippincott, MD; Aniket Sidhaye, MD; and Catherine D. Zhang, MD.
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)
Endocrine Society staff involved in developing content for this activity reported no relevant financial relationships.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The activity is not supported by educational grant(s) or other funds from any commercial supporters.